• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM
Click for more information
2.54% 30.3¢

IMMUTEP LIMITED - Charts / Financials

Market Cap $439.4M  ! watchlist Created with Sketch. Add to my watchlist

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 12.37pm 22/07/2024 (20 minute delay) ?
Day
Open 30.0¢   Day High 30.5¢   Day Low 30.0¢
Daily Volume 608443
Bids   Sellers
Number Price Volume   Number Price Volume
27 30.0¢ 452206   15 30.5¢ 172873

Directors & Senior Management

Mr. Marc Voigt Chief Executive Officer, Executive Director
Ms. Deanne Miller Chief Operating Officer, General Counsel, Joint Company Secretary
Dr. Frederic Triebel Chief Scientific Officer, Executive Director
Mr. Florian D. Vogl Chief Medical Officer
Ms. Indira Naidu Joint Company Secretary
Dr. Russell John Howard Independent Non-Executive Chairman of the Board
Mr. Peter A. Meyers Independent Non-Executive Deputy Chairman of the Board
Ms. Lis Boyce Non-Executive Director
Ms. Anne Anderson Independent Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
30.3¢ 		Change
0.008(2.54%) 		Mkt cap ! $439.4M
Open High Low Value Volume
30.0¢ 30.5¢ 30.0¢ $184.3K 608.4K

Buyers (Bids)

No. Vol. Price($)
27 452206 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 172873 15
View Market Depth
Last trade - 13.00pm 22/07/2024 (20 minute delay) ?
Last
30.5¢ 		  Change
0.008 ( 3.25 %)
Open High Low Volume
30.5¢ 30.5¢ 30.0¢ 242615
Last updated 12.37pm 22/07/2024 ?

Top Stories

Large fault structure and uranium anomalies picked up by Infini at Newfoundland play

Infini Resources Ltd has revealed the presence of a large fault structure connected to anomalies at its Portland Creek uranium project.
High-grade copper results provide some relief to 29Metals after earlier mine shutdown 29Metals Ltd has reported positive results from a 3-hole program of drilling in Queensland, finding up to 4.8% copper.
HBF to throw 10% vote behind NDC BidCo's buyout of Pacific Smiles Group Pacific Smiles Group has confirmed 10% shareholder HBF – the private health insurer – will vote in favour of PSQ's buyout by NDC BidCo.
Pure Hydrogen inks MOU for 5 hydrogen buses in Saigon – days after Twiggy's FFI reeled back in Pure Hydrogen has confirmed it's executed an MOU with a Vietnam-based entity to develop hydrogen-fuelled buses.
Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery The week that was: Donald Trump accidentally dodges bullet, China's Third Plenum a non-event & pervasive RBA August move mystery.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.